Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M York

Showing results (281-290 of 477) with videos related to

Pageof 48
Sort By:
Neurobiology of Aging|January 20, 2022
The detrimental effects of APOE4 on risk for Alzheimer's disease may result from altered dendritic spine density, synaptic proteins, and estrogen receptor alphaLisa R Taxier, Sarah M Philippi, Jason M York, et al.
British Journal of Clinical Pharmacology|August 1, 1991
Metabolism of the aldose reductase inhibitor ALO1567 in manY H Park, J E Hudson, R C Barker, et al.
FEMS Microbiology Reviews|March 20, 2026
Synthetic Soils for Ecological and Synthetic Biology ApplicationsJack Orebaugh, Alyssa A Carrell, Larry M York, et al.
Foot & Ankle International|April 2, 2025
Patients With Higher Resilience Report Greater Improvement in Global Physical Health and Pain Interference Following Foot and Ankle SurgeryMichael A Hewitt, Nathaniel E Zona, Shayne M York, et al.
Journal of Ocular Pharmacology|January 1, 1989
The prevention of biochemical changes in lens, retina, and nerve of galactosemic dogs by the aldose reductase inhibitor AL01576M F Lou, J E Dickerson, M L Chandler, et al.
Pharmacology, Biochemistry, and Behavior|August 11, 2004
Modafinil facilitates performance on a delayed nonmatching to position swim task in ratsChristopher P Ward, John R Harsh, Kaki M York, et al.
Human & Experimental Toxicology|October 19, 1999
Haemotoxicity of chloramphenicol succinate in the CD-1 mouse and Wistar Hanover ratJ A Turton, D Yallop, C M Andrews, et al.
Journal of Pharmaceutical Sciences|July 1, 1988
High-performance liquid chromatographic assay of the aldose reductase inhibitor spiro-(2-fluoro-9H-fluorene-9,4'-imidazolidine)-2',5'-dione (AL01567) in plasma and urine and its pharmacokinetics in humansY H Park, B A McCue, R E Dobbs, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1991
Treatment of Pseudomonas infections in peritoneal dialysis patientsT E Taber, T F Hegeman, S M York, et al.
International Journal of Biological Macromolecules|February 1, 1997
Effect of o-acyl substituents on the functional behaviour of Rhizobium meliloti succinoglycanM J Ridout, G J Brownsey, G M York, et al.
Pageof 48

Showing results (281-290 of 477) with videos related to

Sort By:
Pageof 48
Neurobiology of Aging|January 20, 2022
The detrimental effects of APOE4 on risk for Alzheimer's disease may result from altered dendritic spine density, synaptic proteins, and estrogen receptor alphaLisa R Taxier, Sarah M Philippi, Jason M York, et al.
British Journal of Clinical Pharmacology|August 1, 1991
Metabolism of the aldose reductase inhibitor ALO1567 in manY H Park, J E Hudson, R C Barker, et al.
FEMS Microbiology Reviews|March 20, 2026
Synthetic Soils for Ecological and Synthetic Biology ApplicationsJack Orebaugh, Alyssa A Carrell, Larry M York, et al.
Foot & Ankle International|April 2, 2025
Patients With Higher Resilience Report Greater Improvement in Global Physical Health and Pain Interference Following Foot and Ankle SurgeryMichael A Hewitt, Nathaniel E Zona, Shayne M York, et al.
Journal of Ocular Pharmacology|January 1, 1989
The prevention of biochemical changes in lens, retina, and nerve of galactosemic dogs by the aldose reductase inhibitor AL01576M F Lou, J E Dickerson, M L Chandler, et al.
Pharmacology, Biochemistry, and Behavior|August 11, 2004
Modafinil facilitates performance on a delayed nonmatching to position swim task in ratsChristopher P Ward, John R Harsh, Kaki M York, et al.
Human & Experimental Toxicology|October 19, 1999
Haemotoxicity of chloramphenicol succinate in the CD-1 mouse and Wistar Hanover ratJ A Turton, D Yallop, C M Andrews, et al.
Journal of Pharmaceutical Sciences|July 1, 1988
High-performance liquid chromatographic assay of the aldose reductase inhibitor spiro-(2-fluoro-9H-fluorene-9,4'-imidazolidine)-2',5'-dione (AL01567) in plasma and urine and its pharmacokinetics in humansY H Park, B A McCue, R E Dobbs, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1991
Treatment of Pseudomonas infections in peritoneal dialysis patientsT E Taber, T F Hegeman, S M York, et al.
International Journal of Biological Macromolecules|February 1, 1997
Effect of o-acyl substituents on the functional behaviour of Rhizobium meliloti succinoglycanM J Ridout, G J Brownsey, G M York, et al.
Pageof 48